United States (US) Animal Model Market (2025-2031) Outlook | Value, Revenue, Share, Size, Analysis, Industry, Companies, Growth, Forecast & Trends

Market Forecast By Animal Type (Rat, Mice, Guinea Pigs, Rabbits, Others), By Application (Drug Discovery & Development, Basic Research, Others), By End Users (Pharma & Biotech Companies, Academic Research Institutes, Others) And Competitive Landscape
Product Code: ETC406857 Publication Date: Oct 2022 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Vasudha No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

United States (US) Animal Model Market Synopsis

The United States Animal Model Market is a rapidly growing industry driven by the increasing demand for animal models in biomedical research, drug development, and testing. Key factors contributing to this growth include advancements in genetic engineering technologies, rising prevalence of chronic diseases, and the need for personalized medicine. The market is segmented based on type (mice, rats, rabbits, etc.), application (research, drug discovery, toxicology), and end-user (pharmaceutical companies, academic institutions, research organizations). With a strong presence of leading biotechnology and pharmaceutical companies, research institutions, and government funding for life sciences research, the US Animal Model Market is poised for continued expansion. However, ethical concerns, animal welfare regulations, and the emergence of alternative technologies such as in vitro models present challenges to market growth.

United States (US) Animal Model Market Trends

The US Animal Model Market is experiencing several key trends, including a growing demand for genetically modified animal models for research purposes, particularly in the fields of drug development and personalized medicine. There is also a shift towards the use of humanized animal models to better mimic human physiology and disease conditions. Additionally, the market is witnessing an increasing focus on reducing the use of traditional animal models in favor of more ethical and sustainable alternatives such as organoids and in vitro models. Furthermore, there is a rising adoption of advanced technologies like CRISPR/Cas9 gene editing to create more precise and reliable animal models. Overall, these trends indicate a move towards more sophisticated, ethical, and efficient animal models in the US research market.

United States (US) Animal Model Market Challenges

In the US Animal Model Market, challenges primarily stem from ethical considerations surrounding the use of animals in research, leading to increasing pressure from animal rights groups and regulatory bodies. This creates a complex regulatory landscape that researchers must navigate to ensure compliance while also facing the rising costs associated with maintaining and using animal models. Additionally, variability in animal responses, genetic differences, and the potential for discrepancies between animal models and human outcomes present obstacles to the accurate translation of research findings. Furthermore, the need for continuous innovation in animal model development to better mimic human physiology poses a challenge in terms of time and resources. Overall, balancing ethical concerns, regulatory requirements, cost considerations, and scientific accuracy remains a significant challenge in the US Animal Model Market.

United States (US) Animal Model Market Investment Opportunities

The United States Animal Model Market presents various investment opportunities for companies involved in pharmaceuticals, biotechnology, and research industries. With a growing demand for animal models in drug development, disease modeling, and preclinical testing, there is a need for innovative and specialized animal model services and products. Investing in companies that provide genetically engineered mice, rats, and other animal models, as well as services such as breeding, housing, and phenotyping, can be lucrative. Additionally, advancements in CRISPR technology and the increasing focus on personalized medicine offer avenues for growth and differentiation in this market. Collaborations with academic institutions, research organizations, and pharmaceutical companies can also enhance market presence and drive innovation in the US Animal Model Market.

Jordan Agar Market Government Policies

The US Animal Model Market is governed by various policies and regulations aimed at ensuring the ethical treatment and welfare of animals used in research. The primary legislation governing the use of animals in research is the Animal Welfare Act (AWA), enforced by the United States Department of Agriculture (USDA). This act sets forth guidelines for the housing, care, and treatment of animals in research settings. Additionally, institutions conducting research on animals must adhere to the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals, which requires the establishment of Institutional Animal Care and Use Committees (IACUCs) to oversee research protocols involving animals. These regulations are essential in upholding animal welfare standards and promoting ethical research practices within the US Animal Model Market.

United States (US) Animal Model Market Future Outlook

The United States Animal Model Market is expected to witness steady growth in the coming years, driven by the increasing demand for preclinical testing in pharmaceutical and biotechnology research. With a rising focus on personalized medicine and drug development, the use of animal models for studying disease mechanisms and evaluating therapeutic interventions is projected to surge. Advancements in genetic engineering technologies, such as CRISPR-Cas9, are also anticipated to propel market growth by enabling the development of more precise and predictive animal models. Additionally, the growing prevalence of chronic diseases and the need for innovative treatment options are likely to further boost the demand for animal models in research. Overall, the US Animal Model Market is poised for expansion as the biopharmaceutical industry continues to invest in preclinical research and development.

Key Highlights of the Report:

  • United States (US) Animal Model Market Outlook
  • Market Size of United States (US) Animal Model Market, 2024
  • Forecast of United States (US) Animal Model Market, 2031
  • Historical Data and Forecast of United States (US) Animal Model Revenues & Volume for the Period 2021 - 2031
  • United States (US) Animal Model Market Trend Evolution
  • United States (US) Animal Model Market Drivers and Challenges
  • United States (US) Animal Model Price Trends
  • United States (US) Animal Model Porter's Five Forces
  • United States (US) Animal Model Industry Life Cycle
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Animal Type for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Rat for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Mice for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Guinea Pigs for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Rabbits for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Application for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Drug Discovery & Development for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Basic Research for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By End Users for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Pharma & Biotech Companies for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Academic Research Institutes for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Animal Model Market Revenues & Volume By Others for the Period 2021 - 2031
  • United States (US) Animal Model Import Export Trade Statistics
  • Market Opportunity Assessment By Animal Type
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End Users
  • United States (US) Animal Model Top Companies Market Share
  • United States (US) Animal Model Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Animal Model Company Profiles
  • United States (US) Animal Model Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Animal Model Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Animal Model Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Animal Model Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Animal Model Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Animal Model Market - Industry Life Cycle

3.4 United States (US) Animal Model Market - Porter's Five Forces

3.5 United States (US) Animal Model Market Revenues & Volume Share, By Animal Type , 2021 & 2031F

3.6 United States (US) Animal Model Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) Animal Model Market Revenues & Volume Share, By End Users, 2021 & 2031F

4 United States (US) Animal Model Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and targeted therapies

4.2.2 Rising prevalence of chronic diseases requiring extensive research and drug development

4.2.3 Technological advancements in genetic engineering and biotechnology

4.3 Market Restraints

4.3.1 Ethical concerns and regulatory restrictions related to animal testing

4.3.2 High costs associated with maintaining animal facilities and procuring specific animal models

4.3.3 Growing preference for alternative methods like in vitro testing and computational modeling

5 United States (US) Animal Model Market Trends

6 United States (US) Animal Model Market, By Types

6.1 United States (US) Animal Model Market, By Animal Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Animal Model Market Revenues & Volume, By Animal Type , 2021 - 2031F

6.1.3 United States (US) Animal Model Market Revenues & Volume, By Rat, 2021 - 2031F

6.1.4 United States (US) Animal Model Market Revenues & Volume, By Mice, 2021 - 2031F

6.1.5 United States (US) Animal Model Market Revenues & Volume, By Guinea Pigs, 2021 - 2031F

6.1.6 United States (US) Animal Model Market Revenues & Volume, By Rabbits, 2021 - 2031F

6.1.7 United States (US) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F

6.2 United States (US) Animal Model Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Animal Model Market Revenues & Volume, By Drug Discovery & Development, 2021 - 2031F

6.2.3 United States (US) Animal Model Market Revenues & Volume, By Basic Research, 2021 - 2031F

6.2.4 United States (US) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F

6.3 United States (US) Animal Model Market, By End Users

6.3.1 Overview and Analysis

6.3.2 United States (US) Animal Model Market Revenues & Volume, By Pharma & Biotech Companies, 2021 - 2031F

6.3.3 United States (US) Animal Model Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F

6.3.4 United States (US) Animal Model Market Revenues & Volume, By Others, 2021 - 2031F

7 United States (US) Animal Model Market Import-Export Trade Statistics

7.1 United States (US) Animal Model Market Export to Major Countries

7.2 United States (US) Animal Model Market Imports from Major Countries

8 United States (US) Animal Model Market Key Performance Indicators

8.1 Number of new drug approvals correlated with animal model research

8.2 Adoption rate of advanced animal models (e.g., humanized mice, genetically modified animals)

8.3 Research funding allocated to animal model studies

9 United States (US) Animal Model Market - Opportunity Assessment

9.1 United States (US) Animal Model Market Opportunity Assessment, By Animal Type , 2021 & 2031F

9.2 United States (US) Animal Model Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) Animal Model Market Opportunity Assessment, By End Users, 2021 & 2031F

10 United States (US) Animal Model Market - Competitive Landscape

10.1 United States (US) Animal Model Market Revenue Share, By Companies, 2024

10.2 United States (US) Animal Model Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All